v3.25.4
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)
 9 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Cash flows from operating activities:    
Net income $ 206,995,000 $ 185,938,000
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 77,253,000 59,756,000
Stock-based compensation expense 35,688,000 33,464,000
Provision for doubtful accounts 13,977,000 12,918,000
Gain on modification of office lease (13,907,000) 0
Gain on marketable securities (26,088,000) (27,992,000)
Deferred income taxes 11,311,000 5,964,000
Gain on cash surrender value of life insurance policies (8,566,000) (7,253,000)
Impairment of right-of-use assets 0 2,452,000
Impairment of fixed assets 0 509,000
Change in other assets and liabilities:    
Accounts payable and accrued liabilities (65,897,000) (127,755,000)
Receivables due from clients (75,535,000) (35,933,000)
Deferred compensation 24,710,000 39,860,000
Unearned compensation (25,578,000) (13,803,000)
Income taxes and other receivables (11,661,000) (13,347,000)
Income taxes payable (278,000) (7,364,000)
Prepaid expenses and other assets (11,737,000) 4,279,000
Other (13,179,000) (3,144,000)
Net cash provided by operating activities 117,508,000 108,549,000
Cash flows from investing activities:    
Purchase of property and equipment (65,083,000) (42,191,000)
Proceeds from sales/maturities of marketable securities 45,857,000 33,428,000
Purchase of marketable securities (29,625,000) (31,916,000)
Premium on company-owned life insurance policies (28,175,000) (28,213,000)
Proceeds from life insurance policies 3,355,000 612,000
Cash paid for acquisitions, net of cash acquired 0 (44,442,000)
Dividends received from unconsolidated subsidiaries 0 40,000
Net cash used in investing activities (73,671,000) (112,682,000)
Cash flows from financing activities:    
Dividends paid to shareholders (76,368,000) (58,576,000)
Repurchases of common stock (37,625,000) (73,920,000)
Payments of tax withholdings on restricted stock (19,071,000) (17,053,000)
Proceeds from issuance of common stock in connection with an employee stock purchase plan 7,516,000 7,868,000
Dividends - noncontrolling interest (3,656,000) (3,038,000)
Principal payments on finance leases (1,498,000) (1,211,000)
Payments on life insurance policy loans (272,000) (519,000)
Net cash used in financing activities (130,974,000) (146,449,000)
Effect of exchange rate changes on cash and cash equivalents 18,538,000 (11,125,000)
Net decrease in cash and cash equivalents (68,599,000) (161,707,000)
Cash and cash equivalents at beginning of period 1,006,964,000 941,005,000
Cash and cash equivalents at end of the period $ 938,365,000 $ 779,298,000

Source

PDF